Global Robotic Biopsy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In July 2022, the United States Food and Drug Administration (FDA) cleared the integration of Intuitive’s robotic-assisted platform into Siemens Healthineers’ mobile imaging for minimally invasive lung biopsies. The novel integration would enable Intuitive to offer 2D- and 3D- imaging in its Ion System during procedures.

• In March 2022, Biobot Surgical announced an MOU with BEBIG Medical to work together to provide a robotic-guided high dose rate (HDR) brachytherapy solution for prostate cancer treatment.

The global market for robotic biopsy devices can be segmented into several key categories based on various factors such as product type, application, end-user, and geography. Each segment plays a crucial role in shaping the overall growth and dynamics of the market.

These are fixed-position devices that use robotic arms to guide biopsy needles precisely to targeted tissue sites. They are often used in surgical settings for procedures requiring high precision. These are smaller, more compact devices designed for use in interventional radiology or outpatient settings. They offer flexibility in maneuverability and are capable of performing biopsies in various anatomical locations.Robotic biopsy devices find applications across different medical specialties, including:

Predominantly used for the diagnosis and staging of cancers, robotic biopsy devices allow for precise tissue sampling, aiding in treatment planning and monitoring.Used in procedures such as endomyocardial biopsy to diagnose heart conditions, robotic devices enhance accuracy and reduce procedural risks.Employed for brain biopsies, where precise targeting is critical to avoid damage to sensitive neurological structures.

Utilized for biopsies in the digestive tract, enabling targeted sampling of lesions or abnormalities detected during endoscopic procedures. Major adopters due to their comprehensive facilities and the ability to handle complex procedures requiring robotic assistance.Increasingly adopting robotic biopsy devices for outpatient procedures due to their compact size and ease of integration into existing workflows.

Utilize robotic biopsy devices for experimental purposes and clinical trials aimed at advancing diagnostic capabilities and treatment outcomes.The market for robotic biopsy devices exhibits regional variations influenced by factors such as healthcare infrastructure, technological adoption rates, and regulatory environments. Key geographical segments include:Leading market due to high healthcare expenditures, advanced medical infrastructure, and early adoption of technological innovations.Significant market share, driven by increasing prevalence of chronic diseases and favorable reimbursement policies supporting robotic-assisted procedures.Emerging as a rapidly growing market, fueled by expanding healthcare infrastructure, rising disposable incomes, and growing awareness about advanced medical technologies.

Each of these segments contributes uniquely to the overall growth trajectory of the global robotic biopsy devices market. As technology continues to evolve and healthcare providers seek to enhance diagnostic precision and patient outcomes, the market is expected to expand further, driven by ongoing innovations and increasing adoption across diverse medical specialties and geographical regions.

Global Robotic Biopsy Devices Segment Analysis

In this report, the Global Robotic Biopsy Devices Market has been segmented by Product,End User Application, and Geography.

Global Robotic Biopsy Devices Market, Segmentation by Product

The Global Robotic Biopsy Devices Market has been segmented by Product into Systems and Instrument & Accessories.

The global robotic biopsy devices market is segmented by product type into systems and instruments & accessories, reflecting the diverse components and functionalities that constitute these advanced medical devices.Robotic biopsy systems encompass the core robotic platforms used for guiding and performing biopsy procedures. These systems typically include:

Central to the system, robotic arms equipped with articulated joints and precise control mechanisms enable surgeons to maneuver biopsy instruments with high accuracy and dexterity.Advanced imaging modalities, such as ultrasound, MRI, or CT, are often integrated into robotic systems to provide real-time visualization of the target tissue and surrounding structures during the biopsy procedure.Software algorithms play a crucial role in planning biopsy trajectories, optimizing instrument positioning, and providing feedback to ensure precise tissue sampling.Instruments and accessories complement robotic biopsy systems, enhancing their functionality and versatility across different medical specialties. These components include:Specialized needles and probes designed for accurate tissue sampling and retrieval during robotic-assisted procedures. These instruments are tailored for various biopsy types, such as core biopsies or fine-needle aspirations.

Accessories such as guide wires, cannulas, and catheters aid in navigating through anatomical structures to reach the biopsy target site with precision. Includes sterile drapes, covers, and other disposable items necessary for maintaining aseptic conditions during robotic biopsy procedures.Additional tools like suction devices, specimen retrieval systems, and tissue marking systems contribute to efficient biopsy sample collection and post-procedural management.

Segmenting the market into systems and instruments & accessories allows healthcare providers and stakeholders to understand the distinct roles and technological advancements within each category. Systems form the backbone of robotic biopsy capabilities, integrating robotics and imaging for precise procedural execution, while instruments & accessories support these systems by providing specialized tools tailored to specific biopsy requirements and procedural needs. This segmentation underscores the comprehensive approach in advancing robotic biopsy technologies to enhance diagnostic accuracy, improve patient outcomes, and expand the application scope across various medical specialties globally.

Global Robotic Biopsy Devices Market, Segmentation by Application

The Global Robotic Biopsy Devices Market has been segmented by Application Outlook into Lung Biopsy, Brain Biopsy, Prostate Biopsy and Other Biopsies.

Lung biopsy procedures using robotic technology are critical for diagnosing pulmonary conditions, such as lung cancer or interstitial lung diseases. Robotic systems offer precise needle placement and real-time imaging guidance, allowing clinicians to access and sample lung lesions located deep within the lung parenchyma. This capability minimizes the risk of complications and enhances diagnostic accuracy, particularly in cases where traditional biopsy methods may be challenging due to lesion location or patient factors.

Robotic biopsy devices are increasingly employed in neurosurgical procedures to obtain tissue samples from brain lesions or tumors. The intricate nature of brain anatomy necessitates high precision and minimal tissue disturbance, both of which robotic systems can provide. Advanced imaging integration and robotic arm maneuverability enable neurosurgeons to navigate through delicate brain structures safely and extract tissue samples for accurate diagnosis and treatment planning. This application is vital in neurology for diagnosing brain tumors, infections, or neurological disorders requiring tissue analysis.

In urology, robotic biopsy devices are utilized for prostate biopsies to diagnose prostate cancer and monitor disease progression. These devices facilitate targeted sampling of prostate tissue guided by imaging modalities such as MRI or ultrasound. Robotic systems offer enhanced needle control and maneuverability within the confined pelvic area, improving biopsy accuracy and reducing the likelihood of complications. This application benefits from the ability to precisely sample suspicious areas identified through imaging, aiding in personalized treatment decisions for patients with prostate cancer.

Beyond lung, brain, and prostate biopsies, robotic biopsy devices find application in various other anatomical sites and medical specialties. Examples include biopsies in gastroenterology for detecting gastrointestinal cancers or inflammatory bowel diseases, dermatology for skin lesion analysis, and gynecology for sampling ovarian or uterine tissues. The versatility of robotic systems allows for adaptation to different biopsy procedures across diverse medical fields, supporting comprehensive diagnostic evaluations and therapeutic interventions.

Segmenting the market by application outlook underscores the specific clinical needs and challenges addressed by robotic biopsy devices in different anatomical areas and medical conditions. These applications highlight the growing adoption of robotic technology in enhancing diagnostic precision, improving patient outcomes, and expanding the scope of minimally invasive biopsy procedures across global healthcare settings.

Global Robotic Biopsy Devices Market, Segmentation by End User

The Global Robotic Biopsy Devices Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, Academic & Research Institutes.

The global robotic biopsy devices market is significantly influenced by various end-users such as hospitals, ambulatory surgical centers, and academic and research institutes. Hospitals, being one of the largest users of robotic biopsy devices, typically employ these technologies to assist in conducting precise, minimally invasive biopsies across a variety of specialties, such as oncology and neurology. Robotic systems in hospitals enhance procedural accuracy, reduce recovery time, and minimize patient discomfort, making them an attractive option for both healthcare providers and patients. The demand for these devices is growing as hospitals continue to adopt advanced technologies for better patient outcomes and to streamline complex procedures.

Ambulatory surgical centers (ASCs) also represent a substantial end-user segment within the robotic biopsy devices market. These centers, focusing on outpatient procedures, benefit from the efficiency and precision offered by robotic biopsy devices. The ability to perform accurate and minimally invasive biopsies in an outpatient setting helps reduce operational costs while offering patients quicker recovery times compared to traditional surgical methods. ASCs are increasingly adopting robotic systems as they aim to provide high-quality care in a cost-effective manner. The technological advantages offered by robotic biopsy devices make them particularly suited for ASCs, where both speed and precision are crucial.

Academic and research institutes play a crucial role in the advancement and development of robotic biopsy devices, contributing to the growth of this market. These institutions conduct studies that explore the potential of robotic technologies in biopsy procedures and evaluate their effectiveness in various clinical scenarios. Researchers are continually working to improve the capabilities of robotic systems, focusing on automation, artificial intelligence integration, and new applications in medical diagnostics. As the demand for innovative solutions in healthcare rises, academic and research institutions remain pivotal in refining these technologies and expanding their uses, influencing both the future of robotic biopsy devices and their market growth.

Global Robotic Biopsy Devices Market, Segmentation by Geography

In this report, the Global Robotic Biopsy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Robotic Biopsy Devices Market Share (%), by Geographical Region, 2024

The global robotic biopsy devices market share by geographical region varies, reflecting regional healthcare infrastructures, technological adoption rates, and regulatory environments influencing market dynamics.

North America typically holds a significant share of the global robotic biopsy devices market. This is driven by advanced healthcare infrastructure, high healthcare expenditures, and early adoption of technological innovations. The region benefits from robust research and development activities, strong presence of key market players, and favorable reimbursement policies supporting the adoption of robotic-assisted procedures.

Europe also commands a considerable market share for robotic biopsy devices. Countries within the region exhibit high healthcare standards, extensive regulatory frameworks promoting medical device innovations, and increasing prevalence of chronic diseases necessitating advanced diagnostic tools. Adoption rates vary among European nations, influenced by economic factors, healthcare system efficiency, and access to technology.

The Asia-Pacific region is experiencing rapid growth in the robotic biopsy devices market. Factors such as expanding healthcare infrastructure, rising disposable incomes, and increasing healthcare expenditures contribute to market expansion. Countries like China, Japan, and India are key contributors due to large patient populations, growing awareness of advanced medical technologies, and initiatives to improve healthcare quality and access.

Latin America holds a smaller but growing share of the global market. Market growth is driven by improving healthcare access, rising prevalence of chronic diseases, and efforts to enhance healthcare infrastructure and technology adoption. Economic factors, regulatory challenges, and varying healthcare policies influence market dynamics across Latin American countries.

This report provides an in depth analysis of various factors that impact the dynamics of Global Robotic Biopsy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Technological Advancements in Robotics and Imaging Technologies
• Increasing Incidence of Cancer and Chronic Diseases
• Growing Demand for Minimally Invasive Procedures

• Rising Adoption of Robotic-Assisted Surgeries - The rising adoption of robotic-assisted surgeries represents a significant driver in the global healthcare landscape, particularly in the context of robotic biopsy devices. This trend is reshaping surgical practices across various medical specialties by offering enhanced precision, improved patient outcomes, and operational efficiencies.

  Robotic-assisted surgeries utilize advanced robotic systems equipped with articulated arms and specialized instruments controlled by skilled surgeons. These systems offer several advantages over traditional surgical methods:

  Robotic systems provide unparalleled precision in maneuvering instruments within the body, allowing surgeons to perform complex procedures with greater accuracy. This precision is crucial in biopsy procedures where targeted tissue sampling is essential for accurate diagnosis and treatment planning.

  Robotic systems enable minimally invasive surgery (MIS), which involves smaller incisions compared to traditional open surgeries. This results in reduced trauma to surrounding tissues, less postoperative pain, faster recovery times, and shorter hospital stays for patients.

  Most robotic systems are equipped with high-definition cameras that provide magnified, 3D views of the surgical site. This improved visualization helps surgeons navigate anatomical structures more effectively and identify critical tissues for biopsy sampling.

Restraints

• High Initial Costs and Maintenance Expenses
• Concerns Regarding Robotic Device Safety and Efficacy
• Limited Availability of Skilled Healthcare Professionals

• Stringent Regulatory Approval Processes - Collaborations and partnerships for technological advancements play a crucial role in fostering innovation and driving growth in the global market for robotic biopsy devices. These initiatives bring together expertise, resources, and capabilities from different organizations to accelerate the development and commercialization of advanced technologies. Here’s how collaborations and partnerships are shaping the landscape:

  Collaborations allow companies to leverage complementary expertise across fields such as robotics, medical imaging, artificial intelligence (AI), and biotechnology. By combining knowledge and skills, partners can tackle complex challenges more effectively and develop robust solutions for robotic biopsy devices.

  Partnerships enable faster innovation cycles by sharing research and development (R&D) efforts, thereby reducing time-to-market for new technologies. This agility is critical in the rapidly evolving healthcare sector where staying ahead of technological advancements is key to maintaining competitiveness.

  Collaborative efforts provide access to shared resources such as funding, infrastructure, and intellectual property. This facilitates the exploration of new ideas, experimentation with novel technologies, and scaling up of manufacturing capabilities for robotic biopsy devices.

  Working in partnership allows for collaborative validation studies and clinical trials, which are essential for demonstrating the safety, efficacy, and clinical utility of new robotic biopsy devices. Additionally, partners can navigate regulatory pathways more efficiently by pooling knowledge of regulatory requirements and compliance strategies.

Opportunity

• Expansion of Applications Beyond Oncology (e.g., Cardiology, Neurology)
• Development of Portable and Compact Robotic Biopsy Devices
• Integration of Artificial Intelligence (AI) for Enhanced Diagnostic Capabilities

• Collaborations and Partnerships for Technological Advancements - The maintenance of accuracy and precision in complex procedures is a critical challenge and focus area in the development and adoption of robotic biopsy devices. These devices are designed to enhance the precision of tissue sampling, which is crucial for accurate diagnosis and effective treatment planning in various medical specialties.

  Robotic biopsy devices incorporate advanced robotics, imaging technologies, and real-time feedback mechanisms to achieve precise targeting and sampling of tissues. Technologies such as robotic arms with articulated joints and high-resolution imaging systems enable surgeons to navigate anatomical structures with unprecedented accuracy.

  Ensuring accuracy involves continuous monitoring and calibration of robotic systems throughout the procedure. Robotic biopsy devices are equipped with sensors and software algorithms that monitor factors such as instrument positioning, tissue interaction, and feedback from imaging modalities. This real-time feedback helps maintain alignment and adjust trajectories as needed to optimize biopsy sampling accuracy.

  The proficiency of healthcare professionals operating robotic biopsy devices is crucial. Comprehensive training programs and ongoing education ensure that surgeons and interventionalists develop the necessary skills to utilize robotic systems effectively. Mastery of robotic interfaces and understanding of anatomical variability contribute to maintaining precision in complex procedures.

  AI algorithms are increasingly integrated into robotic biopsy devices to enhance accuracy and decision-making capabilities. AI-driven systems can analyze real-time data from imaging scans, predict optimal biopsy targets, and recommend adjustments based on patient-specific factors and procedural complexities. This integration supports surgeons in achieving consistent and precise tissue sampling outcomes.

  Pre-procedural planning using advanced imaging techniques, such as MRI and CT scans, coupled with AI algorithms, allows for patient-specific planning of robotic biopsy procedures. This personalized approach helps identify optimal biopsy sites, navigate around critical structures, and minimize risks associated with invasive procedures.

Key players in Global Robotic Biopsy Devices Market include :

• Medtronic
• Renishaw plc
• iSYS Medizintechnik GmbH
• Mazor Robotics
• Biobot Surgical Pte Ltd
• Medrobotics
• Medtech SA

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis